Table 3.

Crizotinib treatment outcomes.

	Overall	Line of treatment
		1st line	2nd line	3rd line	Other
		(n = 136)	(n = 148)	(n = 36)	(n = 20)
	n (%)	n (%)	n (%)	n (%)	n (%)
Complete response	28 (7.6)	8 (6.2)	16 (11.2)	3 (9.4)	1 (5.6)
Partial response	199 (54.2)	77 (59.2)	93 (65.0)	17 (53.1)	9 (50.0)
Stable disease	40 (10.9)	14 (10.8)	18 (12.6)	4 (12.5)	3 (16.7)
Progressive disease	62 (16.9)	31 (23.8)	16 (11.2)	8 (25)	5 (27.8)
Objective response rate	227 (61.9)	85 (65.5)	109 (76.2)	20 (62.5)	10 (55.6)
Disease control rate	267 (72.8)	99 (76.3)	127 (88.8)	24 (75.0)	13 (72.3)